What does an earnings surprise mean?

An earnings surprise is the difference between a company's reported EPS or revenue and the analysts' consensus estimate. A positive surprise means results exceeded expectations, while a negative surprise means results fell short.

How can earnings reports affect IRMD stock?

Earnings reports can increase volatility in IRMD stock, especially when reported EPS, revenue or company guidance differs from market expectations. An earnings beat does not always lead to a price increase, as investors also consider the outlook, valuation and broader market conditions.

IRadimed Corp Earnings Dates & Reports

This page offers detailed IRadimed Corp earnings data including the latest IRadimed Corp earnings report, the upcoming IRadimed Corp earnings date, historical data and IRadimed Corp earnings call news.

IRMD Latest Quarter’s Earnings

Announce Date7/31/2026

EPS Actual (USD)0.41

Revenue Actual (USD)20.47M

IRMD Upcoming Quarter's Earnings

Announce Date--

EPS Forecast (USD)--

Revenue Forecast (USD)--

IRMD FY2025 Earnings

EPS (YoY)1.7716.40%

Revenue (YoY)83.81M14.43%

IRadimed Corp (IRMD) Earnings History

Release Date	Period End	EPS/Forecast	Revenue/Forecast	EPS Surprise %	Revenue Surprise %
7/31/2026	06/2026	0.41/0.42	20.47M/20.35M	-2.82%	0.57%
5/1/2026	03/2026	0.46/0.45	21.98M/21.32M	2.28%	3.12%
2/10/2026	12/2025	0.51/0.48	22.69M/21.60M	5.37%	5.06%
11/3/2025	09/2025	0.44/0.46	21.20M/20.50M	-3.65%	3.43%
8/1/2025	06/2025	0.45/0.43	20.41M/20.01M	4.39%	2.02%
5/5/2025	03/2025	0.37/0.41	19.51M/19.33M	-10.08%	0.92%
2/13/2025	12/2024	0.41/0.44	19.39M/19.14M	-7.78%	1.28%
10/31/2024	09/2024	0.40/0.39	18.33M/18.10M	3.52%	1.26%

IRadimed Corp Earnings News

Iradimed Q2 2026 earnings: 3870 pump transition compresses margins

Iradimed reported Q2 2026 revenue of $20.5 million, up 0.5% year over year, while GAAP diluted EPS fell 9% to $0.41 and gross margin declined to 74% from 78%. The launch and production ramp of the new 3870 MRI-compatible IV pump weighed on pump revenue and manufacturing efficiency, even as patient-monitor, disposables, and ferromagnetic-detection sales increased. Operating cash flow fell 23% to $5.9 million, but free cash flow rose to $5.5 million as capital spending dropped. Management reaffirmed full-year 2026 revenue and EPS guidance.

TradingKeyWed, Aug 5

IRadimed Corp